NDC product
Doxepin Hydrochloride
NDC 10267-5060 · Contract Pharmacal Corp.
Key facts
| Product NDC | 10267-5060 |
|---|---|
| Proprietary name | Doxepin Hydrochloride |
| Nonproprietary name | Doxepin Hydrochloride |
| Substances | DOXEPIN HYDROCHLORIDE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Labeler | Contract Pharmacal Corp. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA213474 |
| Pharmacologic classes | Tricyclic Antidepressant [EPC] |
| Marketing start | Jan 24, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: